GERM

Amplify Treatments, Testing and Advancements ETF
GERM

Overview Fund Activity
Delisted

GERM was delisted on the 5th of September, 2024.

Back to rankings

30 hedge funds and large institutions have $9.18M invested in Amplify Treatments, Testing and Advancements ETF in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
30
Holders Change
+6
Holders Change %
+25%
% of All Funds
0.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
4
Reduced
8
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
RJFSA
Raymond James Financial Services Advisors
Florida
$769K
2
Jane Street
Jane Street
New York
$392K
3
IWM
IHT Wealth Management
Illinois
$426K
4
CHC
City Holding Co
West Virginia
$11K
5
Commonwealth Equity Services
Commonwealth Equity Services
Massachusetts
$602K

Top Sellers

1
Citadel Advisors
Citadel Advisors
Florida
$0
2
G
Gainplan
Michigan
$0
3
WS
Wedbush Securities
California
$214K
4
Osaic Holdings
Osaic Holdings
Arizona
$764K
5
Simplex Trading
Simplex Trading
Illinois
$15K
Name Holding Trade Value Shares
Change 		Shares
Change %
SCA
26
Snowden Capital Advisors
New York
$7K +$7K +200 New
BHWM
27
Beaird Harris Wealth Management
Texas
$3K +$3K +86 New
TWA
28
TCI Wealth Advisors
Arizona
$1K -$500 -10 -33%
Royal Bank of Canada
29
Royal Bank of Canada
Ontario, Canada
$1K +$1K +26 New
Citadel Advisors
30
Citadel Advisors
Florida
– -$347K -8,465 Closed
G
31
Gainplan
Michigan
– -$246K -6,000 Closed
DA
32
DCM Advisors
New York
– -$86K -2,100 Closed
1
2